Research/art/teacher profile of a person
Name and surname:
MUDr. Darina Slezáková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Slezáková
I.2 - Name
Darina
I.3 - Degrees
M.D., Ph.D
I.4 - Year of birth
1982
I.5 - Name of the workplace
2nd Department of Neurology, Comenius University Faculty of Medicine and University Hospital Bratislava
I.6 - Address of the workplace
Office of the Dean, Faculty of Medicine, Comenius University, Špitálska 24, 813 72 Bratislava, Slovakia
I.7 - Position
Assistant Professor
I.8 - E-mail address
darinaslezak@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/26263
I.10 - Name of the study field in which a person works at the university
neurology
I.11 - ORCID iD
0009-0007-2182-987X

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2007
II.c - Study field and programme
General Medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Slovak Medical University in Bratislava
II.b - Year
2012
II.c - Study field and programme
neurology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2012
II.c - Study field and programme
neurology/PhD.
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
University Teacher – Assistant Professor Comenius University in Bratislava, Faculty of Medicine – 2nd Department of Neurology, Faculty of Medicine, Comenius University and University Hospital Bratislava 2017 – present
Physician – Neurologist University Hospital Bratislava – 2nd Department of Neurology, Faculty of Medicine, Comenius University and University Hospital Bratislava 2007-present

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Neurológia 1+2 v slovenskom a anglickom jazyku General Medicine I.+II. General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
O
V.4.b - Diploma (second degree)
3
V.4.c - Dissertation (third degree)
0
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
4
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
106
VI.1.b - Over the last six years
29
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
5
VI.1.b - Over the last six years
2
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
91
VI.1.b - Over the last six years
91
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
83
VI.1.b - Over the last six years
83
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
12
VI.1.b - Over the last six years
8
VI.2 - The most significant research/artistic/other outputs
1

Slezáková, Darina a kol. Sclerosis multiplex a príbuzné demyelinizačné ochorenia CNS [textový dokument (print)] . – 1. vyd. – Bratislava (Slovensko) : A-medi management, 2025. – 480 s. [36,79 AH] [tlačená forma] : text. – ISBN 978-80-69053-14-4.

[učebnica pre vysoké školy]

[OV 180 Lekárske, farmaceutické a nelekárske zdravotnícke vedy] [ŠO 5141 všeobecné lekárstvo]

2

Slezáková D, Adamová LM, Marček P, Kadlic P, Konečná M, Valkovič P, Minár M. A supplementary training program integrating cold exposure, breathing exercises and mindfulness as a complementary treatment for neuropsychological aspects of multiple sclerosis - a pilot interventional study. Mult Scler Relat Disord. 2025 Apr 16;99:106450 IF: 2.9 - 2023, Q2 Clinical neurology Ohlasy: 0

3

Adamová LM, Slezáková D, Hric I, Nechalová L, Berisha G, Olej P, Chren M, Chlapcová A, Penesová A, Minár M, Bielik V. Impact of dance classes on motor and cognitive functions and gut microbiota composition in multiple sclerosis patients: Randomized controlled trial. Eur J Sport Sci. 2024 Aug;24(8):1186-1196, IF: 2.4 - 2023, Q2 Sport sciences, Ohlasy 1

4

Slezáková D, Kadlic P, Jezberová M, Boleková V, Valkovič P, Minar M. Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy. Neurol Neurochir Pol. 2023;57(3):282-288, IF: 2.9 - 2023, Q2 -Clinical neurology Ohlasy 16

5

Marček P, Kadlic P, Adamová LM, Tóthova Ľ, Pastorek M, Kovalčíkova AG, Valkovič P, Minár M, Slezáková D. Extracellular DNA and Deoxyribonuclease Activity as Potential Biomarkers of Inflammation in Multiple Sclerosis. Mol Neurobiol. 2025 Apr 8. doi: 10.1007/s12035-025-04907-4. Epub ahead of print. PMID: 40198446, IF: 4.6 – 2023, Q1- Neurosciences Ohlasy: 0

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Slezáková, Darina a kol. Sclerosis multiplex a príbuzné demyelinizačné ochorenia CNS [textový dokument (print)] . – 1. vyd. – Bratislava (Slovensko) : A-medi management, 2025. – 480 s. [36,79 AH] [tlačená forma] : text. – ISBN 978-80-69053-14-4.

[učebnica pre vysoké školy]

[OV 180 Lekárske, farmaceutické a nelekárske zdravotnícke vedy] [ŠO 5141 všeobecné lekárstvo]

2

Slezáková D, Adamová LM, Marček P, Kadlic P, Konečná M, Valkovič P, Minár M. A supplementary training program integrating cold exposure, breathing exercises and mindfulness as a complementary treatment for neuropsychological aspects of multiple sclerosis - a pilot interventional study. Mult Scler Relat Disord. 2025 Apr 16;99:106450 IF: 2.9 - 2023, Q2 Clinical neurology Ohlasy: 0

3

Adamová LM, Slezáková D, Hric I, Nechalová L, Berisha G, Olej P, Chren M, Chlapcová A, Penesová A, Minár M, Bielik V. Impact of dance classes on motor and cognitive functions and gut microbiota composition in multiple sclerosis patients: Randomized controlled trial. Eur J Sport Sci. 2024 Aug;24(8):1186-1196, IF: 2.4 - 2023, Q2 Sport sciences, Ohlasy 1

4

Slezáková D, Kadlic P, Jezberová M, Boleková V, Valkovič P, Minar M. Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy. Neurol Neurochir Pol. 2023;57(3):282-288, IF: 2.9 - 2023, Q2 -Clinical neurology Ohlasy 16

5

Marček P, Kadlic P, Adamová LM, Tóthova Ľ, Pastorek M, Kovalčíkova AG, Valkovič P, Minár M, Slezáková D. Extracellular DNA and Deoxyribonuclease Activity as Potential Biomarkers of Inflammation in Multiple Sclerosis. Mol Neurobiol. 2025 Apr 8. doi: 10.1007/s12035-025-04907-4. Epub ahead of print. PMID: 40198446, IF: 4.6 – 2023, Q1- Neurosciences Ohlasy: 0

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Rossi, S. – Centonze, D. – Koch, M. – Buttmann, M. – Filippi, M.. : Cytokine-driven inflammation and neurodegeneration in multiple sclerosis. – In: Nature Reviews Neurology, vol. 19, no. 4, 2023 ; s. 215–228 ; SCI ; SCOPUS

2

Håkansson, I. – Johansson, E. – Björk, R. – Feresiadou, A. – Svenningsson, A.. : Longitudinal assessment of brain volume and cognition in relapsing multiple sclerosis. – In: Multiple Sclerosis Journal, vol. 30, no. 2, 2024 ; s. 190–202 ; SCI ; SCOPUS

3

Heming, M. – Schulte-Mecklenbeck, A. – Brix, T. – Zrzavy, T. – Lassmann, H.. : Peripheral blood DNAase activity and extracellular DNA in autoimmune disorders. – In: Frontiers in Immunology, vol. 15, 2024 ; art. no. 1289653 ; SCI ; SCOPUS

4

Stojanović, M. – Jović, M. – Dinić, M. – Petrović, A.. : Quality of life and physical activity in multiple sclerosis patients after rehabilitation. – In: Clinical Rehabilitation, vol. 37, no. 1, 2023 ; s. 88–96 ; SCI ; SCOPUS

5

Zrzavy, T. – Lassmann, H. – Höftberger, R.. : Neuroinflammation and neurodegeneration in multiple sclerosis revisited. – In: Acta Neuropathologica, vol. 149, no. 2, 2025 ; s. 159–178 ; SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

VEGA/1/0514/25: Use of Electrophysiology in More Precise Diagnosis and Treatment of Cervical Dystonia

Role: Co-investigator

Principal investigator: Assoc. Prof. Michal Minár, M.D., Ph.D.

Grant agency: Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences

Project duration: 2025–2027

2

MZ SR 2018/32-LFUK-6: Use of Kinematic Analysis in a Virtual Reality Environment for the Differential Diagnosis of Gait Disorders and Fall Prevention in the Aging Population

Role: Co-investigator

Principal investigator: Prof. Peter Valkovič, M.D., Ph.D.

Grant agency: Ministry of Health of the Slovak Republic

Project duration: 2018–2020

3

Novartis Scientific Grant No. 77275381: Effect of Physical and Nutritional Intervention on Gut Microbiota, Functional Metabolomics, and Clinical Biomarkers in Patients with Multiple Sclerosis

Role: Principal investigator

Grant agency: Novartis Slovakia, Ltd.

Project duration: 2023–2024

4

Roche Scientific Grant No. 2022GSD0026: Long-term Effect of Physical and Nutritional Intervention on Gut Microbiota, Functional Metabolomics, and Laboratory and Clinical Biomarkers in Patients with Multiple Sclerosis

Role: Principal investigator

Grant agency: Roche Slovakia, Ltd.

Project duration: 2022–2023

5

Roche Scientific Grant No. 2022GSD0055: Long-term Effect of Physical and Nutritional Intervention on Gut Microbiota, Functional Metabolomics, and Laboratory and Clinical Biomarkers in Patients with Multiple Sclerosis

Role: Principal investigator

Grant agency: Roche Slovakia, Ltd.

Project duration: 2023–2024

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Barts Health NHS Trust (St Bartholomew’s Hospital) London, United Kingdom 30.11.-2.12. 2016 Professor Gavin Giovannoni, MBBCh, PhD, FCP (Neurology), FRCP

IX. - Other relevant facts

Date of last update
2025-11-04